These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21256377)

  • 1. Double-dose clopidogrel in patients undergoing PCI for ACS.
    Vassiliou V
    Lancet; 2011 Jan; 377(9762):297; author reply 298. PubMed ID: 21256377
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-dose clopidogrel in patients undergoing PCI for ACS.
    Schiele F
    Lancet; 2011 Jan; 377(9762):297; author reply 298. PubMed ID: 21256376
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.
    Cuisset T; Frere C; Quilici J; Poyet R; Gaborit B; Bali L; Brissy O; Morange PE; Alessi MC; Bonnet JL
    J Am Coll Cardiol; 2009 Sep; 54(13):1149-53. PubMed ID: 19761935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter by Potter and Le Lorier regarding article, "Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome".
    Potter BJ; Le Lorier J
    Circulation; 2010 Aug; 122(5):e414; author reply e415. PubMed ID: 20679578
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
    Mehta SR; Tanguay JF; Eikelboom JW; Jolly SS; Joyner CD; Granger CB; Faxon DP; Rupprecht HJ; Budaj A; Avezum A; Widimsky P; Steg PG; Bassand JP; Montalescot G; Macaya C; Di Pasquale G; Niemela K; Ajani AE; White HD; Chrolavicius S; Gao P; Fox KA; Yusuf S;
    Lancet; 2010 Oct; 376(9748):1233-43. PubMed ID: 20817281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The CURRENT-OASIS 7 study].
    Ardissino D; Patti G; Magnani G; Mantovani F; Demola MA
    G Ital Cardiol (Rome); 2011 Mar; 12(3):167-71. PubMed ID: 21560471
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
    ; Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Eikelboom JW; Fox KA; Granger CB; Jolly S; Joyner CD; Rupprecht HJ; Widimsky P; Afzal R; Pogue J; Yusuf S
    N Engl J Med; 2010 Sep; 363(10):930-42. PubMed ID: 20818903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of combining proton pump inhibitors and clopidogrel.
    Kapoor JR
    Am J Cardiol; 2009 Jun; 103(11):1624. PubMed ID: 19463530
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute coronary syndromes: finding meaning in OASIS 7.
    Stone GW
    Lancet; 2010 Oct; 376(9748):1203-5. PubMed ID: 20817280
    [No Abstract]   [Full Text] [Related]  

  • 10. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Padrini R; Pengo V
    N Engl J Med; 2010 Dec; 363(25):2465-6; author reply 2467-8. PubMed ID: 21158667
    [No Abstract]   [Full Text] [Related]  

  • 11. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Merella P; Casu G; Meloni I
    N Engl J Med; 2010 Dec; 363(25):2466-7; author reply 2467-8. PubMed ID: 21158665
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton-pump inhibitors could be innocent when used concomitantly with clopidogrel.
    Horiuchi H
    Circ J; 2012; 76(11):2542-3. PubMed ID: 23001019
    [No Abstract]   [Full Text] [Related]  

  • 13. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.
    Nicolau JC; Bhatt DL; Roe MT; Lokhnygina Y; Neely B; Corbalán R; Leiva-Pons JL; Martinez F; Goodman SG; Winters KJ; Verheugt FW; Armstrong PW; White HD; Fox KA; Prabhakaran D; Ohman EM;
    Am Heart J; 2015 Oct; 170(4):683-694.e3. PubMed ID: 26386792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment patterns in acute coronary syndrome patients in the United Kingdom undergoing PCI.
    Bakhai A; Iñiguez A; Ferrieres J; Schmitt C; Sartral M; Belger M; Zeymer U;
    EuroIntervention; 2011 Mar; 6(8):992-6. PubMed ID: 21330248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
    Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
    Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part V. Combination of clopidogrel and acetylsalicylic acid in the treatment of stable patients with atherothrombotic cardiovascular diseases].
    Preobrazhenskiĭ DV; Sidorenko BA; Fettser DV; Batyraliev TA; Niiazova-Karben ZA; Besnili F
    Kardiologiia; 2010; 50(5):73-6. PubMed ID: 20831051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Vassiliou VS
    N Engl J Med; 2010 Dec; 363(25):2466; author reply 2467-8. PubMed ID: 21158666
    [No Abstract]   [Full Text] [Related]  

  • 19. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.
    Parodi G; Marcucci R; Valenti R; Gori AM; Migliorini A; Giusti B; Buonamici P; Gensini GF; Abbate R; Antoniucci D
    JAMA; 2011 Sep; 306(11):1215-23. PubMed ID: 21934054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI.
    Angiolillo DJ; Franchi F; Waksman R; Sweeny JM; Raveendran G; Teng R; Zhao Y; Carlson G; Khan N; Mehran R
    J Am Coll Cardiol; 2016 Feb; 67(6):603-613. PubMed ID: 26868683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.